Catalyst Biosciences Stock Return On Asset
| CBIODelisted Stock | USD 0.41 0.02 4.65% |
Catalyst Biosciences fundamentals help investors to digest information that contributes to Catalyst Biosciences' financial success or failures. It also enables traders to predict the movement of Catalyst Stock. The fundamental analysis module provides a way to measure Catalyst Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalyst Biosciences stock.
Catalyst |
Catalyst Biosciences Company Return On Asset Analysis
Catalyst Biosciences' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Catalyst Biosciences Return On Asset | -0.38 |
Most of Catalyst Biosciences' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalyst Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Catalyst Biosciences has a Return On Asset of -0.3824. This is 95.63% lower than that of the Biotechnology sector and 98.38% lower than that of the Health Care industry. The return on asset for all United States stocks is 173.14% higher than that of the company.
Catalyst Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalyst Biosciences' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalyst Biosciences could also be used in its relative valuation, which is a method of valuing Catalyst Biosciences by comparing valuation metrics of similar companies.Catalyst Biosciences is currently under evaluation in return on asset category among its peers.
Catalyst Fundamentals
| Return On Equity | -2.69 | |||
| Return On Asset | -0.38 | |||
| Current Valuation | 51.03 M | |||
| Shares Outstanding | 37.97 M | |||
| Shares Owned By Insiders | 27.73 % | |||
| Shares Owned By Institutions | 8.75 % | |||
| Number Of Shares Shorted | 34.05 K | |||
| Price To Earning | (0.34) X | |||
| Price To Book | 0.53 X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 794 K | |||
| Gross Profit | (64.91 M) | |||
| EBITDA | (52.15 M) | |||
| Net Income | (8.24 M) | |||
| Cash And Equivalents | 75.39 M | |||
| Cash Per Share | 2.39 X | |||
| Total Debt | 38 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 18.86 X | |||
| Book Value Per Share | (0.78) X | |||
| Cash Flow From Operations | (33.1 M) | |||
| Short Ratio | 0.19 X | |||
| Earnings Per Share | (1.50) X | |||
| Price To Earnings To Growth | 0.02 X | |||
| Target Price | 16.0 | |||
| Beta | 1.29 | |||
| Market Capitalization | 19.37 M | |||
| Total Asset | 28.44 M | |||
| Retained Earnings | (410.94 M) | |||
| Working Capital | 11.38 M | |||
| Current Asset | 68.7 M | |||
| Current Liabilities | 37.76 M | |||
| Annual Yield | 7.93 % | |||
| Net Asset | 28.44 M |
About Catalyst Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Catalyst Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalyst Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalyst Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Catalyst Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalyst Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Catalyst Stock
| 0.9 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.88 | HYMTF | Hyundai Motor | PairCorr |
| 0.87 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.85 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.81 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Catalyst Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalyst Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalyst Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalyst Biosciences to buy it.
The correlation of Catalyst Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalyst Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalyst Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catalyst Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |